HCW Biologics Stock (NASDAQ: HCWB) stock price, news, charts, stock research, profile.
Open | $0.67 |
Close | $0.65 |
Volume / Avg. | 11.25K / 21.11K |
Day Range | 0.62 - 0.68 |
52 Wk Range | 0.61 - 2.32 |
Market Cap | $24.47M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 21 |
Short Interest | 0.03% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of HCW Biologics (NASDAQ:HCWB) through any online brokerage.
Other companies in HCW Biologics’s space includes: Vincerx Pharma (NASDAQ:VINC), Aligos Therapeutics (NASDAQ:ALGS), Bolt Biotherapeutics (NASDAQ:BOLT), Palatin Techs (AMEX:PTN) and Viracta Therapeutics (NASDAQ:VIRX).
There is no analysis for HCW Biologics.
HCW Biologics has a consensus price target of $7.50.
The stock price for HCW Biologics (NASDAQ: HCWB) is $0.647 last updated June 28, 2024 at 4:00 PM EDT.
There are no upcoming dividends for HCW Biologics.
HCW Biologics’s Q2 earnings are confirmed for Friday, August 9, 2024.
There is no upcoming split for HCW Biologics.
HCW Biologics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.